Lexaria Bioscience Corp. LEXX 40.85
Health Care · NASDAQ · Data as of 2026-07-13
Lexaria Bioscience Corp. (LEXX) has delivered +25.4% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1397 of 1993 stocks overall and #174 of 264 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
40.85
Overall Rank
#1397 / 1993
Sector Rank
#174 / 264
Revenue CAGR
+25.4%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio